NICOLLE FISCHER: Open Payments
NPI 1588928238 · AMES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,079 in 107 payments from 14 companies in 2025. Trend: 2023 $2,135 · 2024 $1,920 · 2025 $2,079
Food & beverage: $1,881Education: $198
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $471 |
| ABBVIE INC. | 24 | $417 |
| Novartis Pharmaceuticals Corporation | 6 | $228 |
| GENZYME CORPORATION | 11 | $176 |
| E.R. Squibb & Sons, L.L.C. | 9 | $170 |
| Galderma Laboratories, L.P. | 9 | $152 |
| Lilly USA, LLC | 6 | $107 |
| UCB, Inc. | 5 | $92 |
| Organon LLC | 5 | $75 |
| Regeneron Healthcare Solutions, Inc. | 3 | $55 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, Rhapsido, Sotyktu, NEMLUVIO, RINVOQ, Bimzelx.
Industry payments across IA — which companies pay providers there.
